Related Experiment Video
Updated: May 20, 2026
Whole-cell MALDI-TOF Mass Spectrometry is an Accurate and Rapid Method to Analyze Different Modes of Macrophage Activation
Published on: December 26, 2013
[Macrophage activation syndrome]
1Klinik und Poliklinik für Rheumatologie/Klinische Immunologie, Asklepios Klinik Bad Abbach, Kaiser-Karl V.-Allee 3, 93077, Bad Abbach, Deutschland. pe.lehmann@asklepios.com
Abstract:
Macrophage activation syndrome (MAS) is an infrequent but potentially life-threatening complication of various autoimmune diseases. It is characterized by excessive activation of macrophages induced by a dysfunction of the immune system, although the underlying abnormalities remain to be delineated. Sepsis-like symptoms accompanied by cytopenia, hepatosplenomegaly, coagulopathy and multiple organ dysfunctions are typical disease manifestations. Due to the lack of validated classification criteria and distinct laboratory markers, the diagnosis of MAS is often difficult to establish. However, early diagnosis and therapy is of utmost importance to ensure best possible outcome. Treatment regimens include high doses of glucocorticoids, classical immunosuppressive agents as well as novel biologics.
Insights
Macrophage activation syndrome (MAS) is a severe autoimmune complication with sepsis-like symptoms. Early diagnosis and treatment are crucial for better patient outcomes.
Area of Science:
- Immunology
- Rheumatology
- Pathophysiology
Context:
- Macrophage activation syndrome (MAS) is a rare but life-threatening condition.
- It is associated with various autoimmune diseases, indicating immune system dysfunction.
- The exact underlying abnormalities driving MAS require further elucidation.
Purpose:
- To highlight the diagnostic challenges of MAS.
- To emphasize the critical need for early diagnosis and intervention.
- To outline current and emerging therapeutic strategies for MAS.
Summary:
- MAS involves excessive macrophage activation, leading to symptoms like cytopenia, hepatosplenomegaly, coagulopathy, and organ dysfunction.
- Diagnosis is difficult due to the absence of validated criteria and specific biomarkers.
- Prompt treatment, including glucocorticoids, immunosuppressants, and biologics, is vital.
Impact:
- Improved understanding of MAS pathophysiology.
- Enhanced diagnostic approaches for clinicians.
- Optimized patient management and therapeutic interventions for MAS.
